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The objective of the study is to ﬁnd out whether the endothelial nitric oxide synthase (eNOS) G894T single-nucleotide polymor-
phism is associated with type 2 diabetes mellitus in South Indian (Tamil) population. A total number of 260 subjects comprising
100 type 2 diabetic mellitus patients and 160 healthy individuals with no documented history of diabetes were included for the
study. DNA was isolated, and eNOS G894T genotyping was performed using the polymerase chain reaction followed by restriction
enzyme analysis using Ban II. The genotype distribution in patients and controls were compatible with the Hardy-Weinberg ex-
pectations (P>0.05). Odds ratio indicates that the occurrence of mutant genotype (GT/TT) was 7.2 times (95% CI = 4.09–12.71)
more frequent in the cases than in controls. Thus, the present study demonstrates that there is an association of endothelial nitric
oxide synthase gene (G894T) polymorphism with diabetes mellitus among South Indians.
1.Introduction
Prevalence of diabetes is increasing globally, and the world-
wide prevalence of diabetes for all age groups was estimated
to be 2.8% in 2000 and is predicted to be 4.4% in 2030 by the
World Health Organisation (WHO) [1]. The total number
of people with diabetes is projected to rise from 171 mil-
lion in 2000 to 366 million in 2030 [1]. India, China, and
theUnitedstatesareamongthetopthreecountriesestimated
to have the highest number of people with diabetes [2]. The
problems associated with this disease are obesity, hyperten-
sion, cardiac disease, diabetic retinopathy, renal failure, dia-
betic neuropathy, albuminuria, and other vascular diseases
[3].
It has been suggested that diabetes mellitus is a patho-
logical condition where a decreased nitric oxide may present.
Nitric oxide (NO) is a substance which is capable of keeping
vascular tone, coagulation, and inﬂammation well balanced.
Nitric oxide is synthesized by endothelial cells from L-argi-
nine and molecular oxygen by endothelial nitric oxide syn-
thase. Decreased NO activity can be caused by impaired pro-
duction of NO, due to uncoupling of receptor-mediated sig-
naltransduction,adeﬁciencyoftheNOsynthase(NOS)sub-
strate l-arginine, or a decreased availability of one or more
cofactors essential for optimal functioning of NOS [4].
Apart from environmental factors contributing to type 2
diabetes, such as obesity, smoking, sedentary lifestyle, and
certain drugs, genetic factors also play a role in the onset of
this disease. Among the genes thus investigated, the endothe-
lial nitric oxide synthase (eNOS) gene has drawn consid-
erable attention because of its substantial contributions to
vascular diseases.
A single-nucleotide polymorphism (G894T) in the gene-
encoding eNOS exon 7 has been discovered [5]. It results
when guanine residue at position 894 in exon 7 of eNOS
gene is replaced by thymine residue (Glutamate—GAG to
Aspartate—GAT) at the codon 298 [5, 6]. The prevalence of
the polymorphism varies in diﬀerent population, which may
be reﬂective of diﬀerent ethnicities. In recent years, eNOS
gene polymorphism have also gained enormous attention
due to their association with diabetes mellitus regulation.
A previous study has investigated the prevalence of this
polymorphismamongSouthIndians[7].Sofar,nostudyhas
beencarriedouttoelucidatetheroleofthispolymorphismin
South Indian patients with type 2 Diabetes mellitus. There-
fore, the present case-control study has been extended to2 Oxidative Medicine and Cellular Longevity
ﬁnd out whether there is any association of this eNOS gene
polymorphism with type 2 diabetes mellitus.
2.Methodology
2.1. Selection of Subjects. A total of 260 unrelated south
Indian(Tamil)malesofage40–55(50 ±6.4yrs),withnohis-
tory of cardiovascular disease, dyslipidemia, hypertension,
renal failures, and so forth, who belonged to south Indian
Tamil ethnicity [7] were included for the study. Out of the
total 260 individuals, 100 of them were type 2 diabetic pa-
tients and 160 of them were nondiabetic controls. Ethical
clearance was obtained. The informed consent was obtained
from the study subjects. The Tamils represented in this study
are the people who not only live in Tamil Nadu, but also
belong to ethnic group from Tamil Nadu. The identity has
historically been primarily linguistic, with Tamils belonging
to those whose ﬁrst language is Tamil. The patients were
characterized as diabetes mellitus based on the fasting blood
glucose concentration. Diabetes mellitus was considered to
be present if the fasting glucose concentration is greater than
126mg/mL. Individuals with normal blood glucose concen-
tration (<126mg/mL) were considered as controls. People
with history of cardiovascular disease, dyslipidemia, hyper-
tension, renal failures, and so forth and those who do not
belongedtosouthIndianTamilethnicitywereexcludedfrom
the study population.
2.2. DNA Extraction. Genomic DNA was isolated from the
frozen blood by salting out procedure. For DNA isolation,
300μL of the blood was used, and the isolated DNA was
stored at −20◦C. The isolated DNA was conﬁrmed by 0.7%
Agarose (HI-Media, Mumbai) gel electrophoresis and quan-
tiﬁed by UV spectrophotometry (Hitachi, Japan).
2.3. PCR Analysis of G894T SNP [7]. PCR analysis was car-
r i e do u ta sp r e v i o u s l yd e s c r i b e d[ 7] using eppendorf master
cycler (Germany). Genomic DNA (∼50ng) was incubated in
a total reaction volume of 50μL containing equal concen-
tration of the forward primer 5  TCC CTG AGG GCA TGA
GGC T-3  (70 picomoles) and reverse primer 5  TGA GGG
TCA CAC AGG TTC CT-3  (Genescriptcorp.,USA),200μM
deoxynucleotide triphosphate, 10X PCR buﬀer pH-8.3 con-
taining 15mM Mgcl2 and 1.5 units of Taq DNA polymerase
(New England Biolabs, Beverly, Mass, USA).
DNA was initially denatured at 95◦C for 5min prior to
ampliﬁcation. PCR ampliﬁcation was accomplished using 30
cycles, consisting of 2 min denaturation at 95◦C, 45sec
annealing at 62◦C, and 1min extension at 72◦C and the ﬁnal
extension included a 1min extension at 72◦C.
2.4. Restriction Enzyme Analysis. Restriction digestion was
performed in a total volume of 10μLa m p l i c o n s ,1 μLN E
buﬀer (50mM potassium acetate, 20mM tris-acetate,
10Mm magnesium acetate, 1mM dithio threitol pH-7.9 at
25◦C) and 8 units of Ban II enzyme (New England Biolabs,
Beverely, Mass, USA). Samples were then incubated for 5hrs
at 37◦C and the digested PCR products were separated by
2.5% agarose gel electrophoresis.
2.5.ConﬁrmationofPCRbyDirectDNASequencing. Selected
PCR ampliﬁed fragments were completely sequenced both
strands in an automated ABI 3100 Genetic Analyser (Banga-
lore GeNei sequencing services, India).
2.6. Statistical Analysis. Categorical data were analyzed using
absolute counts and proportions. The 2 × 2 contingency
tables were constructed to compare the patients and controls
using an odds ratio. The 95% conﬁdence intervals (95% CI)
werealsocalculated.Theallelefrequencieswerecalculatedby
allele counting. Pearson Chi-square (χ2)t e s tw a sp e r f o r m e d
toﬁndthestatisticalsigniﬁcancebetweentheobservedgeno-
types and expected genotypes of the selected population.
3. Results and Discussion
The “T” allele frequency of the controls obtained in this
study (0.15) is comparable to the “T” allele frequency ob-
served in the previous study [7], which was conducted
among the same South Indian (Tamil) population. Chi-
square analysis at 5% level of signiﬁcance showed that the
study population lies in the Hardy-Weinberg equilibrium
(P>0.05).
In the present study, the occurrence of mutant genotype
(eNOS-894 GT/TT) was found to be high (75%) in type 2
diabetic patients when compared with the controls (29.37%)
(Table 1). A similar study conducted by Monti [8]d e s c r i b e d
a signiﬁcant association between endothelial nitric oxide
synthase (eNOS) gene polymorphism and type 2 diabetes,
suggesting a new genetic susceptibility factor for hyperin-
sulinemia, insulin resistance, and type 2 diabetes mellitus.
It has been shown that there is a signiﬁcant association of
eNOS-G894T single-nucleotide polymorphism with end-
stagerenaldisease[9].Aﬁve-yearprospectivestudyconduct-
ed among Chinese subjects reported that the eNOS G894T
polymorphism appears to be predictive of persistent hyper-
glycemiainindividualswithimpairedglucosetolerance[10].
A previous study conducted among healthy South Indi-
ans reported the absence of homozygous mutant genotype
(eNOS-894 TT) [7]. The results of the present study also
indicate the complete absence of homozygous mutant geno-
type(eNOS-894TT)inthecontrolgroupamongSouthIndi-
ans, whereas another study conducted among North Indians
reported the presence of homozygous mutant genotype
(eNOS-894 TT genotype) among healthy individuals [11].
Such diﬀerences might be attributed to diﬀerent background
or ethnicity that exist between North Indian and South In-
dian ancestry. However, in the present study, mutant geno-
type was observed in individuals with diabetes mellitus.
A study conducted among Asian Indians by Ahluwalia
[12] suggested that that the eNOS gene locus is associated
with diabetic nephropathy and the functional polymor-
phisms (−786T > C & 894G > T) might lead to a decreased
expression of eNOS gene. It has been reported that the “T”
allele is associated with the pathogenesis of diabetic neph-
ropathy in patients with diabetes mellitus [13]. A study con-
ducted among the white Australian population had the in-
creased frequencies of the missense Glu298Asp variant in theOxidative Medicine and Cellular Longevity 3
Table 1: Genotype frequency of the eNOS G894T polymorphism in type 2 diabetes mellitus patients, controls, and total study subjects.
eNOS G894T genotype/allele frequency Genotype frequency n (%) OR (95% CI)
Total subjects n = 260 Patients n = 100 Controls n = 160
GenotypeGG (wild type) 138 (53.07) 25 (25) 113 (71.62 ) 7.213 (4.094–12.706)
GT (heterozygous) 102(39.23) 55 (55) 47 (29.37) 5.289 (2.954–9.470)
TT (mutant) 20 (7.69) 20 (20) — —
Allele G 0.73 0.52 0.85 6.139 (3.123–12.053)
T 0.27 0.48 0.15
eNOS gene, but these were associated with neither the oc-
currence nor the severity of coronary artery disease [14].
A meta-analysis was conducted among 28 association
studies focusing on the three polymorphisms in the NOS3
gene(G894T(Glu289Asp),4b/a,andT-786C)andtheriskof
diabetic nephropathy [15]. It was found out that G894T was
negativelyassociatedwithdiabeticnephropathyinCaucasian
populations of European origin (OR = 0.896, 0.817–0.983,
95% CI), but was positively associated with DN in East Asian
(OR = 2.02, 1.20–3.42, 95% CI) and other populations
In the present study, individuals with the mutant TT ge-
notypehasa7-foldincreasedriskofdevelopingdiabetesmel-
litus. Mutant “T” allele frequency was also found to be high
(0.48) in patients with type 2 diabetes mellitus than the con-
trols(0.15).Thus,heterozygosity/homozygosity(GT/TT)for
the G894T eNOS polymorphism has been associated with
diabetes mellitus. This may be attributed to the decreased
nitric oxide synthase activity in individuals with mutant “T”
allele, which in turn may lead to decreased synthesis of nitric
oxide. However, there is another study conducted among the
same south Indian population associating the eNOS G894T
polymorphism and its relationship with coronary artery di-
sease [16]. The “T” allele frequency observed in that study
(0.12) is comparable to that which is observed in the present
study (0.15). The absence of TT genotype in the control
group could be due to its lower frequent in controls, com-
pared to the patient group, and so, control subjects with TT
genotype could be found if the sample size was larger.
The GAG to GAT substitution in exon 7 (G894T) deter-
mines the conservative replacement of glutamate with aspar-
tate (Glu298Asp), which might cause a tight turn of the α-
helix and, therefore, an increased susceptibility to degrada-
tion [17]. The eNOS G894T variant generates protein prod-
uctswithdiﬀerentsusceptibilitytocleavagethatis,aminoter-
minal 35-kDa and carboxy terminal 100kDa fragments [18].
This suggests that even a single aminoacid substitution could
have a functional eﬀect on the function of the eNOS protein.
Moreover, it has also been demonstrated that this polymor-
phism involves protein-protein interactions with chaperon
proteins that control subcellular traﬃcking of the enzyme as
well as with proteins involved in the degradative processing
[8].
Whilehomozygousmutant“TT”frequencywasfoundto
be high (15%) among Caucasians [19], such condition was
found to be very rare in Asian population [20]. Though the
South Indians are Asians, the type 2 diabetes mellitus pa-
tients among South Indians had “T” allele frequency higher
than that of the controls insisting the association of mutant
“T” allele in type 2 diabetes mellitus.
The role of nitric oxide as a modulator of physiological
insulin secretion has been extensively evaluated [21]. Nitric
oxide has the ability to modulate peripheral and hepatic glu-
cose metabolism and insulin secretion [22]. It has been de-
scribed that eNOS activation, speciﬁcally localized to skeletal
muscle mitochondria, increases muscle blood ﬂow, with in-
creased delivery of insulin’s major substrate, glucose, to the
muscle cell. Thus, genetic defect in the eNOS might be a
new player in the evolution of hyperinsulinemia and insulin
resistance as previously suggested [8].
The frequency of the endothelial nitric oxide synthase
eNOS gene single-nucleotide polymorphisms (SNPs) varies
among ethnic population [23]. The occurrence of diﬀerent
genotype in diﬀerent population may depend on race and
ethnic background of the population. To the best of our
knowledge, this is the ﬁrst study, to relate endothelial nitric
oxide synthase eNOS G894T single-nucleotide polymor-
phism with type 2 diabetes mellitus patients among South
Indians.
To conclude, the present study demonstrates that there is
associationofendothelialnitricoxidesynthasegene(G894T)
polymorphism with diabetes mellitus among South Indians.
This has to be further substantiated by analyzing large num-
ber of samples and also evaluating the level of nitric oxide
in patients with G894T variant. Further studies including
other eNOS polymorphisms (intron 4b/4a, T786C, repeats
inintron13,1998C/G)andtotherelatedbiochemicalparam-
eters including nitric oxide estimation would better explain
whether there is actual decrease of nitric oxide level in pa-
tientswithtype2diabetesmellitusandwhetherbyincreasing
the NOS activity the risk could be reduced for developing
diabetes mellitus.
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